Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases
Renaud Felten, Maxime Dubois, Manuel F. Ugarte‐Gil, et al.
Lara D. Veeken (2021) Vol. 60, Iss. SI, pp. SI68-SI76
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study
Renaud Felten, Lou Kawka, Maxime Dubois, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 9, pp. e613-e615
Open Access | Times Cited: 89
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
G. Fragoulis, Vassiliki-Kalliopi Bournia, Eugenia Mavrea, et al.
Rheumatology International (2021) Vol. 42, Iss. 1, pp. 31-39
Open Access | Times Cited: 40
Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic
Amy Fuller, Jennie E. Hancox, Kavita Vedhara, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0267769-e0267769
Open Access | Times Cited: 19
Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases
Julie J. Paik, Jeffrey A. Sparks, Alfred H.J. Kim
Current Opinion in Pharmacology (2022) Vol. 65, pp. 102243-102243
Open Access | Times Cited: 17
Vaccine hesitancy in patients with autoimmune diseases: Data from the coronavirus disease-2019 vaccination in autoimmune diseases study
Latika Gupta, Parikshit Sen, JamesB Lilleker, et al.
Indian Journal of Rheumatology (2022) Vol. 17, Iss. 2, pp. 188-188
Open Access | Times Cited: 14
Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination
Jie Lü, Yuwei He, Robert Terkeltaub, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 8, pp. 1189-1193
Open Access | Times Cited: 13
Global Perspective on the Impact of the COVID‐19 Pandemic on Rheumatology and Health Equity
Evelyn Hsieh, Dzifa Dey, Rebecca Grainger, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 22-31
Closed Access | Times Cited: 7
Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries
Lina El Kibbi, Mona Metawee, Ihsane Hmamouchi, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 3, pp. e160-e163
Open Access | Times Cited: 14
Rheumatic disease patient decision-making about COVID-19 vaccination: a qualitative analysis
Yomei Shaw, Sara Hustek, Nina Nguyen, et al.
BMC Rheumatology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study
Carol Hitchon, Dawn M. E. Bowdish, Gilles Boire, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1061-1061
Open Access | Times Cited: 1
Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review
Silke Neusser, Anja Neumann, Pauline zur Nieden, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002562-e002562
Open Access | Times Cited: 7
COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases
Guillermo Arturo Guaracha-Basáñez, Irazú Contreras-Yáñez, Everardo Álvarez-Hernández, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 12, pp. 5038-5047
Open Access | Times Cited: 10
Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study
Guillermo Arturo Guaracha-Basáñez, Irazú Contreras-Yáñez, Everardo Álvarez-Hernández, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 6
How to optimize recruitment strategies of patients with rheumatic and musculoskeletal diseases for online surveys: experience from an international study
Ihsane Hmamouchi, Antonella Abi Najm, Lina El Kibbi, et al.
Rheumatology International (2022) Vol. 43, Iss. 4, pp. 705-712
Open Access | Times Cited: 6
Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis
Andrea Lyon, Alannah Quinlivan, Sue Lester, et al.
ACR Open Rheumatology (2023) Vol. 5, Iss. 2, pp. 84-92
Open Access | Times Cited: 3
COVID-19 vaccine acceptance and related behavioral and psychological characteristics in individuals with mental disorders in Korea
Seunghyong Ryu, Hangoeunbi Kang, Ha-Ran Jung, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 3
Psychological and Personality Characteristics Associated With COVID-19 Vaccination Behavior in Korean General Population
Seunghyong Ryu, Ju‐Wan Kim, Ju‐Yeon Lee, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 30
Open Access | Times Cited: 3
Perspectives and experiences of COVID-19 vaccination in people with autoimmune and inflammatory rheumatic disease
David Peng, Ayano Kelly, Bernadette Brady, et al.
Patient Education and Counseling (2023) Vol. 118, pp. 107996-107996
Open Access | Times Cited: 3
COVID-19 vaccination experience in patients with rheumatoid arthritis treated at a single VA medical center
Sarah Abi Doumeth, Jenny Gong, Laura Silversteyn, et al.
Vaccine X (2023) Vol. 14, pp. 100295-100295
Open Access | Times Cited: 2
Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study
Ioana Andreica, Iulia Roman, Imke Redeker, et al.
RMD Open (2023) Vol. 9, Iss. 2, pp. e002875-e002875
Open Access | Times Cited: 2
Influenza vaccine coverage among healthcare workers: A cluster analysis from a cross-sectional survey
Anastasia Saade, Fanjanirina Rasoloarivalona, J. Poinsignon, et al.
Infectious Diseases Now (2023) Vol. 53, Iss. 7, pp. 104740-104740
Open Access | Times Cited: 2
COVID-19 and influenza vaccine-hesitancy subgroups
Karl Otto Mäki, Linda C. Karlsson, Johanna K. Kaakinen, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0308159-e0308159
Open Access
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study
Carol Hitchon, Dawn M. E. Bowdish, Gilles Boire, et al.
(2024)
Open Access
Exploring the Barriers and Facilitators to Vaccination among the Immunocompromised Population: A Scoping Review
Anne Ejiegbu, Melody Shayanfar, Mario Brondani
(2024)
Closed Access
Factors Associated With COVID-19 Vaccine Hesitancy in Rheumatology Outpatients in New York City
Medha Barbhaiya, Brandon Schneider, Jonah M. Levine, et al.
JCR Journal of Clinical Rheumatology (2023) Vol. 30, Iss. 1, pp. e1-e8
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top